Skip to content

To evaluate the efficacy and safety of the newly developed low-intensity ultrasound-transcutaneous nerve stimulation combined therapy for knee pain with osteoarthritis for 20 minutes, 3 times a day (more than 10 times a week) for a total of 8 weeks Single-institution, double-blind, randomized, parallel design, study-based clinical trials

To evaluate the efficacy and safety of the newly developed low-intensity ultrasound-transcutaneous nerve stimulation combined therapy for knee pain with osteoarthritis for 20 minutes, 3 times a day (more than 10 times a week) for a total of 8 weeks Single-institution, double-blind, randomized, parallel design, study-based clinical trials

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003883
Enrollment
40
Registered
2019-05-03
Start date
2017-11-10
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The mediation used in this study Device name: Low intensity ultrasound - transcutaneous nerve stimulation combined therapy device Permission: medical combination stimulator (grade 2)

Sponsors

Chonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults aged 19 and over, under 65 years of age 2) who were diagnosed with Kellgren-Lawrence (K-L) scale on anteroposterior plane radiograph of the knee in standing posture 3) Those who fully understand the purpose of the research and wish to participate in the clinical research through voluntary consent

Exclusion criteria

Exclusion criteria: 1) Those who do not meet the age criteria 2) Persons suspected of having neurological disorders on physical examination 3) Those who appeal for sensory depression 4) Those who underwent knee surgery within the last 6 months 5) Those who have undergone lower limb surgery and cortisone injections treatment within the past month (including steroids, nonsteroidal anti-inflammatory drugs, etc.)

Design outcomes

Primary

MeasureTime frame
Visual analog scale

Secondary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index

Countries

Korea, Republic of

Contacts

Public ContactSEUNG-ROK KANG

Chonbuk National University Hospital

srkang@mdctc.or.kr+82-63-259-3458

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 21, 2026